top of page
Life Sci. 2019 May 1;224:232-240. doi: 10.1016/j.lfs.2019.03.069. Epub 2019 Mar 28.
Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts.
Tanaka K, Kondo H, Hamamura K, Togari A
Research Library
The largest, free collection of academic references related to restorative reproductive medicine— made possible by donations.
bottom of page